Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.


CSE:BUX - Post by User

User Avatar Image
(1)
•••
  • PrussianfellowX
Post by Prussianfellowon Apr 23, 2023 1:38pm
226 Views
Post# 35409419

Nice uptrend thanks to insiders

Nice uptrend thanks to insidersThe current share price has moved up nicely to .25

However this is due to the almost daily trades of two insiders often a few hundred dollars per trade or less.

Not sure how the CSE allows this, as this is obvious shareprice manipulation.

In my opinion, with the poor business model but decent science behind Biomark, this stock should be in the 5 to 10 cent range.

Many of us long term investors got taken twice now going back to 2014.

I know there are many disgruntled German investors that ran this up to the $1 range almost ten years ago and then saw this collapse to 5 cents.

Another batch of investors including me saw this run up to 70 cents, only to see the company too cheap to continue a simple promo to maintain price support then see this fall down to .11 cents during the past two years.

The management have shown us some good promise on the science side, but they have not cared about the average investor.

I will only buy more if this is at or below 10 cents based on the science.

This company does not care about past or present investors.

The insiders have demonstrated almost daily they play share price support games.

GLTA

<< Previous
Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities